{"title": "SHANK genes in autism: Defining therapeutic targets.", "text": "", "journal": ["Progress in neuro-psychopharmacology & biological psychiatry", "Prog. Neuropsychopharmacol. Biol. Psychiatry"], "id": "29175319", "doi": "10.1016/j.pnpbp.2017.11.019", "date": "2017-11-22", "authors": [["Mossa", "Adele", "A", "CNR Neuroscience Institute, Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy."], ["Giona", "Federica", "F", "CNR Neuroscience Institute, Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy."], ["Pagano", "Jessica", "J", "CNR Neuroscience Institute, Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy."], ["Sala", "Carlo", "C", "CNR Neuroscience Institute, Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy."], ["Verpelli", "Chiara", "C", "CNR Neuroscience Institute, Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy. Electronic address: c.verpelli@in.cnr.it."]]}